BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Share Circulation

Deep News08:32

BIOSTAR PHARM-B (02563) announced that the company has received a filing notice issued by the China Securities Regulatory Commission (CSRC) on February 5, 2026. According to the notice, the company has completed the filing with the CSRC regarding the implementation of an H-share full circulation arrangement. The filing notice will remain valid for 12 months from the date of issuance. The company will apply to the Stock Exchange for the conversion and listing of the shares.

As of the date of this announcement, specific details of the implementation plan for the conversion and listing have not been finalized. The company will issue further announcements regarding the progress and details of the conversion and listing in accordance with the Listing Rules and applicable laws at the appropriate time.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1119636136?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-09 08:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119636136","market":"fut","top_or_hot":-1,"title":"BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Share Circulation","media":"Deep News","content":"<p>BIOSTAR PHARM-B (02563) announced that the company has received a filing notice issued by the China Securities Regulatory Commission (CSRC) on February 5, 2026. According to the notice, the company has completed the filing with the CSRC regarding the implementation of an H-share full circulation arrangement. The filing notice will remain valid for 12 months from the date of issuance. The company will apply to the Stock Exchange for the conversion and listing of the shares.</p>\n<p>As of the date of this announcement, specific details of the implementation plan for the conversion and listing have not been finalized. The company will issue further announcements regarding the progress and details of the conversion and listing in accordance with the Listing Rules and applicable laws at the appropriate time.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BIOSTAR PHARM-B Receives CSRC Filing Notice for Full Share Circulation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBIOSTAR PHARM-B Receives CSRC Filing Notice for Full Share Circulation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-02-09 08:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BIOSTAR PHARM-B (02563) announced that the company has received a filing notice issued by the China Securities Regulatory Commission (CSRC) on February 5, 2026. According to the notice, the company has completed the filing with the CSRC regarding the implementation of an H-share full circulation arrangement. The filing notice will remain valid for 12 months from the date of issuance. The company will apply to the Stock Exchange for the conversion and listing of the shares.</p>\n<p>As of the date of this announcement, specific details of the implementation plan for the conversion and listing have not been finalized. The company will issue further announcements regarding the progress and details of the conversion and listing in accordance with the Listing Rules and applicable laws at the appropriate time.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09939","symbol_name":"开拓药业-B","start_time":0,"source_url":"","article_id":"1119636136","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119636136","pubTimestamp":1770597152,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"BIOSTAR PHARM-B (02563) announced that the company has received a filing notice issued by the China Securities Regulatory Commission (CSRC) on February 5, 2026. According to the notice, the company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","09939":"开拓药业-B","BK1161":"生物科技","BK1574":"生物医药B类股","02563":"华昊中天医药-B","BK1515":"抗疫概念"},"translate_title":"映泰医药-B收到证监会股票全流通备案通知书","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"02563":1,"09939":1},"content_text":"BIOSTAR PHARM-B (02563) announced that the company has received a filing notice issued by the China Securities Regulatory Commission (CSRC) on February 5, 2026. According to the notice, the company has completed the filing with the CSRC regarding the implementation of an H-share full circulation arrangement. The filing notice will remain valid for 12 months from the date of issuance. The company will apply to the Stock Exchange for the conversion and listing of the shares.\nAs of the date of this announcement, specific details of the implementation plan for the conversion and listing have not been finalized. The company will issue further announcements regarding the progress and details of the conversion and listing in accordance with the Listing Rules and applicable laws at the appropriate time.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1119636136","isCrawlerRequest":true}